Skip to Main Content

Paper Details

Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.
J Nucl Med
7
2022
Patients, Prostate Cancer
Author NameAffiliation
Gang NiuCenter for Drug Evaluation and Research
Sue-Jane WangCenter for Drug Evaluation and Research
  • 1 - 2

Datasets

Release 1.2